Millions were put at risk due to Monsanto’s deceptive conduct
Increasing evidence suggests that Monsanto was aware of the cancer-causing properties of their product, but refused to recall it or modify the formula in order to continue reaping billions of dollars in profits. This disregard for ethical standards is unforgivable. Take action today by filing a claim to hold mega-corporations Monsanto and Bayer accountable for promoting and distributing a dangerous product to millions of consumers.
Glyphosate, the active ingredient in Roundup, has been deemed a carcinogen by the International Agency for Research on Cancer, a division of the World Health Organization. The public had been uncertain about Roundup’s toxicity due to conflicting claims regarding the connection between the product and cancer diagnoses until recently.
Over the past few years, trials related to Roundup have uncovered how Monsanto concealed the potential hazards from the public through manipulative means.
During the trials, evidence obtained through discovery revealed internal emails from Monsanto personnel expressing concerns about the toxicity of its herbicides, as well as their failure to conduct carcinogenicity testing of their formulations. Furthermore, company scientists were found discussing ghostwriting scientific literature. The trial evidence also uncovered Monsanto’s efforts to cultivate friendly officials within the Environmental Protection Agency (EPA) for support, and secret payments made to groups such as the American Council on Science and Health (ACSH) to promote the safety of Monsanto’s herbicides.
Resolution Reached with Roundup Users Over Cancer Claims
Bayer has reached a $10 billion settlement to resolve cancer-related claims associated with Roundup; however, the company has not agreed to halt the sale of the product or to include any safety warning labels.
Under the settlement agreement, a substantial amount of $8.8 billion to $9.6 billion has been allocated to resolve ongoing litigation and to cover potential claims that have not yet been resolved. In addition, $1.25 billion has been earmarked for future claims from individuals who have developed non-Hodgkin’s lymphoma after using Roundup. A portion of this amount will be used to establish an independent expert panel to evaluate whether glyphosate can cause cancer and determine the safe exposure levels or dosage of the herbicide.
Bayer is still confronting around 30,000 claims from litigants who have not consented to participate in the settlement. Moreover, the corporation has not acknowledged any fault or misconduct.